Background and aim: The protective role of angiotensin type 2 receptors (AT2-Rs) is still controversial. As AT2-Rs are minimally expressed in adult tissues the aim of the current study was to over-express AT2-Rs in rat mesangial cells in order to ascertain their potential role in modulating renal scarring. Methods: Male and female mesangial cells were transiently transfected with AT2-R or control vector then 'injured' with macrophage-conditioned medium (MCM). Culture supernatants and extracted RNA were analysed for evidence of an anti-fibrotic phenotype. Results: Supernatant fibronectin levels in female mesangial cells treated with MCM were reduced in AT2-R transfected cells (p < 0.001) compared to controls. AT2-R transfected male cells showed a trend towards lower constitutive fibronectin levels. There was no effect of AT2-R transfection on TGF-β or TNF-α secretion; however, IL-1β levels were reduced in male cells treated with MCM. RT-PCR demonstrated that constitutive kallikrein mRNA levels were suppressed in both male and female AT2-R transfected cells. Bradykinin receptors (BkB2-R and BkB1-R) were unaffected in female cells although the BkB1-R was upregulated in male cells treated with MCM. Conclusion: This data provides a case for AT2 receptors playing a protective role in rat mesangial cells independent of the effects of blood pressure control.
Introduction
Clinical and experimental studies have suggested that the main effector molecule of the renin-angiotensin system (RAS) angiotensin II (AII) plays an important role in the pathophysiology of various kidney diseases. Most studies have evaluated the effects of blockade of the RAS in conferring renal protection using either angiotensin converting enzyme (ACE) inhibitors or angiotensin type 1 receptor (AT1-R) antagonists. 1 Until recently it was thought that the AT1-R was the major receptor mediating the actions of AII, particularly since the angiotensin type 2 receptor (AT2-R) was minimally expressed in adult tissues. 2 However, increasing evidence suggests that AT2-R stimulation counteracts the classic pressor effects mediated by AT1-R activation.
The functional activity of AT2-R is most pronounced during AT1-R antagonism. 3 During this time AII synthesis is increased because of inhibition of the short negative feed back loop on renin secretion and AT2-R-binding affinity is enhanced. These effects result in further stimulation of the AT2-R. AII occupancy of the unopposed AT2-Rs mediates a compensatory vasodilatory response. The theory that AT2-R have a counter regulatory role to AII stimulation of AT1-R is supported by studies demonstrating pressor hypersensitivity to AII in mice lacking AT2-R, and prevention of the hypotensive response to AT1-R blockade by selective antagonism of AT2-R. 3, 4 AT2-R also play a beneficial role beyond blood pressure control. Morrissey and Klahr demonstrated, in the rat unilateral ureteral obstruction model, that antagonising the AT2-R exacerbated renal fibrosis by removing the counter regulatory mechanisms that would oppose the profibrotic effects of AII operating via the AT1-R. 5 Moreover, other investigators have demonstrated that over-expression of AT2-R in 5/6 nephrectomised mice is protective on glomeruli, reducing expression of TGF-β and PDGF agents known to promote glomerular extracellular matrix accumulation and cell proliferation. 6 However, there is still some controversy regarding the beneficial functions of the renal AT2-R since they have been shown to be 're-expressed' in response to injury. 7 Moreover, some investigators have demonstrated beneficial effects in experimental renal disease after AT2-R antagonism. 8 Whether the AT2-R exerts additional protective effects in terms of end organ damage during renal injury beyond blood pressure control is a topic of much research. Studies have shown that AT2-R binding is known to mediate a range of effects, which could be beneficial in renal injury such as vasodilation, suppression of proliferation, cell differentiation, apoptosis, tissue regeneration, 9 nitric oxide release and vascular kinin system activation. 10 However, in vivo studies make it very difficult to distinguish the effects mediated by blood pressure control from other locally mediated effects.
New evidence is now emerging demonstrating novel mechanisms of AII receptor regulation beyond the classical AII-mediated actions described. These include the dimerisation of AII receptors, the oligomerisation of AII receptors with novel receptor interacting proteins and the demonstration that AII receptor activation can occur in the absence of classical ligand binding. 11 AT2-R over-expression has been shown to affect cells in a ligand-independent fashion increasing bradykinin and NO synthase production in vascular smooth muscle cells 12 and inducing apoptosis in prostate cancer cells. 13 A greater understanding of AT2-R activity and regimens to modify its expression in the kidney, may contribute to the development of novel therapeutic approaches to halt the progression of renal disease. Therefore the proposed aim of the study was to over-express AT2-R in rat mesangial cells in order to ascertain whether increased expression alone has the potential to modulate renal scarring. As we have previously found that gender can affect the way cells respond to treatment, 14 and since the renin-angiotensinaldosterone system appears to be regulated by sex hormones (reviewed by Komukai et al. 15 ) we carried out the AT2-R transfection experiments on both male and female mesangial cells.
Materials and methods

Cell culture
Mesangial cell were cultured from the glomerular explants of age-matched adult male and female Wistar rat kidneys (University of Leicester colony) using standard techniques. Three male and three female rats were used from which six 'cell lines' were generated. The cells were cultured in RPMI 1640 (Invitrogen, Paisley, UK) supplemented with 20% heat inactivated foetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml streptomycin, 5 µg/ml insulin and 2 mM glutamine. Cultured cells were characterised as mesangial by their typical stellate, fusiform morphology, their positive staining for the Thy-l antigen and their resistance to the toxic effects of D-valine and PAN. Cells of passage 2 through 8 were used.
Transformation of Escherichia coli with AT2-R plasmid
Escherichia coli were transformed with plasmid containing AT2-R (gift from Dr Kevin Burns, Department of Medicine, Ottawa Hospital and the Kidney Research Centre, Ottawa Health Research Institute, University of Ottawa, Ontario, Canada) and plated out on selective agar. Positive white colonies were selected and expanded in culture. The plasmids from each culture were extracted, purified, digested and analysed for presence of AT2-R gene insert. The colony exhibiting the strongest expression of the AT2-R was cultured up on a large scale for extraction and purification of plasmid-insert construct for use in transfection experiments.
Mesangial cell transfection
Mesangial cells (80% confluent) were transiently transfected with the AT2 receptor gene using the mammalian expression vector pCR 3.3-Uni containing the 1.163 kb DNA fragment incorporating the entire open reading frame of rat AT2 receptor 16 (gift from Dr Kevin Burns). Control animals were transfected with vector alone.
Rat mesangial cells were transfected with either AT2-R plasmid or control plasmid (without insert) using a proprietary cationic, lipid agent Transfast™ (Promega). Transfected cells were cultured in RPMI containing 5% fetal calf serum (FCS). Mesangial cells were 'injured' with macrophage-conditioned medium (MCM) or were exposed to medium alone (controls).
TRIzol RNA. Total RNA was extracted from cells after 48 h using TRIzol (Invitrogen) according to the manufacturer's instructions.
RT-PCR. One microgram RNA from each treatment was reverse transcribed with the AMV reverse transcription system (Promega). PCR reactions were carried out using specific primers and using ABgene PCR mastermix (ABgene, Epsom, UK).
All primers were custom made by Invitrogen (Table 1) . Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as the house-keeping gene to normalise for loading. The number of cycles used allowed quantification without saturation. The amplicons were resolved on 1% agarose gels. The bands were visualised on a BioRad gel doc 2000 and quantified on a BioRad GS 700 imaging densitometer.
Preparation of macrophage-conditioned medium
Macrophage conditioned medium (MCM) was prepared from lipopolysaccharide (LPS)-stimulated, RAW 264.7 cells. RAW cell were cultured in RPMI + 10% FCS and grown to confluence in 25 cm 2 flasks. The cells were then washed three times with Hank's balanced salt solution (HBSS) before being stimulated with 1 µg/ml LPS in serum free RPMI for 24 h. After stimulation the cells were washed three times in HBSS and then incubated in serum free RPMI for a further 3 days. The culture supernatants were then removed centrifuged at 1000 rpm for 5 min to generate the macrophage conditioned medium.
Preparation of cell proteins
Cell proteins were prepared using the TRIzol method following extraction of RNA as directed by the manufacturer.
Protein assay
Cell proteins were assayed using a commercial BioRad DC protein assay kit using BSA standards (BioRad, Hemel Hempstead, UK).
Measurement of fibronectin production
Culture supernatants or cell lysates were assayed for fibronectin using an inhibition ELISA as previously described. 23 
Measurement of TGF-β, TNF-α and IL-1β
Rat TGF-β, TNF-α and IL-1β were measured using Quantikine ELISA kits (R&D Systems, Oxford, UK) according to manufacturer's instructions.
In all the ELISA assays the data is presented as units of antigen divided by cell protein.
Gelatin zymography
Culture supernatants were mixed 1:1 with non-denaturing sample buffer and resolved at 4°C on 8% SDSpolyacrylamide gels containing 2.5 mg/ml gelatin. The gels were washed in 2.5% Triton X 100 for approximately 1 h after which they were incubated overnight at 37°C in pH 7.6 developer buffer (50 mol/l Tris-HCl, 100 mmol/l, NaCl, 10 mmol/l CaCl 2 , 0.05% Brij). The gels were then stained with Brilliant Blue R® and destained with a solution of 40% methanol/10% acetic acid. Destained gels were dried and bands of lysis scanned using a BioRad Imaging densitometer (model GS-700). 5′-CTC ACC AGC GCC AGC CGA CTT AT-3′  17  Anti-sense  5′-GGC ACT GAG GAA TGA TCT AA-3′  MMP2 Sense
Statistical analysis
As we have previously found that gender can affect the way cells respond to treatment, 14 we carried out the AT2-R transfection experiments on both male and female mesangial cells derived from three different male and three different female Wistar rats (six rats in total). Results are presented as mean ± SEM. To compare values between multiple groups an analysis of variance (ANOVA) with Bonferroni correction was applied. Statistical significance was defined as p < 0.05.
Results
Transfection of mesangial cells with AT2-R
To determine whether transfection of mesangial cell with the AT2-R construct had been successful we carried out an AT2-R RT-PCR on RNA extracted from mesangial cells transfected with the AT2-R construct or with vector alone (control). Results showed that AT2-R transfected cells exhibited much stronger AT2-R mRNA expression than control cells. The faint bands seen in control cells correspond to constitutive expression of AT2-R in mesangial cells (Figure 1 ).
Effect of AT2-R over-expression on fibronectin levels
In order to determine whether AT2-R over-expression had any effect on mesangial cell fibronectin secretion in response to injury with MCM we carried out fibronectin ELISAs on mesangial cell culture supernatants.
The ELISAs demonstrated that fibronectin levels in the supernatants of female mesangial cells injured with MCM were significantly lower in AT2-R transfected cells compared to control transfected cells treated with MCM (p < 0.001). Male cells showed a trend towards lower basal fibronectin levels in AT2-R transfected cells compared to control transfected cells ( Figure 2 ). AT2-R transfection appeared to have no effect on male cells treated with MCM.
Effect of AT2 transfection on matrix metalloproteinase levels
The matrix metalloproteinases MMP9 and MMP2 are known to be involved in the modulation of matrix turnover. RT-PCR demonstrated that AT2-R over-expression had no observable effect on MMP9 mRNA levels, although the pattern of expression was different between the sexes (Figure 3a) .
Similarly AT2-R over-expression had no effect on MMP2 mRNA levels and again the pattern of expression was different between the sexes and different to that of MMP9 ( Figure 3b ). Gelatin zymography reflected the mRNA data with lytic activity in female mesangial cell supernatants being higher in control cells (medium alone) compared to those treated with MCM. Little difference in lytic activity was observed between treatments in male cells (Figure 3c ).
Cytokine expression (TGF-β, IL-1β, TNF-α)
As the profibrotic growth factor transforming growth factor (TGF)-β, and the proinflammatory cytokines interleukin (IL)-1β and tumour necrosis factor (TNF)-α are commonly expressed during inflammation and scarring, supernatants from AT2-R and control transfected mesangial cells were analysed for secretion of these cytokines by ELISA.
AT2-R transfection appeared to have no effect on supernatant TGF-β levels or TNF-α levels (Figure 4a and b) .
However, IL-1β secretion in MCM-treated male mesangial cells was lower in AT2-R transfected cells compared to control transfected cells treated with MCM (p < 0.001) ( Figure 4c ).
Effect of AT2-R transfection on AT1-R expression
AT2-R over-expression has previously been shown to downregulate AT1-R expression in vascular smooth muscle cells via the bradykinin/NO pathway, independently of AII binding. 12 RT-PCR was therefore carried out to assess whether AT2-R transfection had any effect on AT1-R expression in mesangial cells. RT-PCR demonstrated that in female AT2-R transfected mesangial cells AT1-R mRNA expression was downregulated in medium-treated cells compared to control transfected cells (p < 0.03) ( Figure 5 ). However, in males AT2-R over-expression resulted in an upregulation of AT1-R mRNA levels in both medium-and MCM-treated cells (p < 0.04 control medium vs. AT2-R Tx medium, p < 0.004 control MCM vs. AT2-R Tx MCM) ( Figure 5 ).
Effect of AT2-R transfection on kallikrein expression
Kallikrein enzyme activity has been reported to be upregulated following AT2-R binding. 24 Moreover, we have previously shown that modulation of kallikrein activity can reduce the pro-fibrotic phenotype of mesangial cells. 25 RT-PCR was carried out on RNA from AT2-R over-expressing and control mesangial cells to determine whether expression of kallikrein was affected by AT2-R over-expression.
AT2-R transfection suppressed constitutive kallikrein mRNA levels in both female and male cells (p < 0.02, p < 0.01 respectively). Moreover, there was a trend towards AT2-R transfection suppressing kallikrein mRNA levels in male cells treated with MCM (p = 0.07) ( Figure 6 ).
Effect of AT2-R transfection on the bradykinin receptors
In order to assess the effect of AT2-R transfection on other parameters associated with the kallikrein-kinin system we investigated the expression of the bradykinin receptors. The constitutively expressed BkB2 receptor is generally considered to be associated with an anti-fibrotic phenotype, while the inducible BkB1 receptor is typically expressed during episodes of inflammation. RT-PCR demonstrated that AT2-R transfection had no effect on BkB2-R or BkB1-R mRNA levels in female mesangial cells ( Figure  7 ). The expression of BkB1-R mRNA was upregulated in male AT2-R transfected cells exposed to MCM (p < 0.003) ( Figure 7) but not in medium treated cells AT2-R transfected cells. Engagement of both bradykinin receptors results in the induction of nitric oxide (NO). RT-PCR demonstrated that there was no effect of AT2-R transfection on the expression of iNOS mRNA, although male cells expressed substantially more message than females. Endothelial NOS expression was not affected by AT2-R transfection in female cells. However, in male AT2-R transfected cells exposed to MCM there was a trend towards an upregulation of eNOS expression (p = 0.06) (Figure 8 ).
Discussion
The precise pathophysiological role of AT2-R in kidney disease is not yet fully understood. There is still much controversy as to whether AT2-R engagement is associated with RT-PCR for renal kallikrein was carried out on RNA extracted from AT2-R and control transfected male and female mesangial cells exposed to MCM or medium alone. Representative agarose gels are shown. Histograms show densitometric data (mean ± SEM) from all experiments (*p < 0.02, ** p < 0.01 control medium vs. AT2-R Tx medium in females and males respectively, n = 3 male, 3 female). renoprotection or renopathogenesis or, in the light of recent evidence, whether classical ligand activation of the AII receptors under certain conditions is actually required. This study aimed to transfect the normally weakly expressed AT2-R into mesangial cells in order to further delineate the function of this receptor in renal injury, particularly in the absence of the confounding effects of blood pressure control.
The study demonstrated that, at least in female mesangial cells, over-expression of the AT2-R resulted in a significant reduction in culture supernatant fibronectin levels in response to injury with MCM. This would lend support to previous studies where blockade of the AT2-R has been shown to increase fibronectin levels in rat arteries. 26 The fact that over-expression of AT2-R appeared to reduce fibronectin in female MCM treated cells may be due to the influence of oestrogen. Oestrogen is known to upregulate AT2-R expression in the uterus and in the pituitary. 27, 28 Similarly, in the aortas of spontaneously hypertensive rats AT2-R expression is greater in females that in males. 29 However, other than possible trace amounts of oestrogen in the FCS no exogenous oestrogen was present under our experimental conditions. Although male MCM-treated cells did not exhibit the same response, there was a trend towards lower baseline fibronectin levels which we have previously shown to be higher in male than in female mesangial cells. 14 TGF-β is known to be a major protagonist in renal scarring. AT2-R over-expression had no effect on MCMinduced TGF-β levels in mesangial cells. These observations are in accord with in vivo studies in transgenic AT2-R overexpressing mice which demonstrated that AII-induced upregulation of TGF-β mRNA expression in left ventricular cardiomyocytes was not significantly different in AT2-R transgenic or wild type mice. 30 However, we found that IL-1β levels were reduced in male MCM-injured mesangial cells over expressing AT2-R. It has previously been reported that IL1-β is able to increase AT2-R mRNA expression in murine R3T3 cells, 31 though the reverse scenario of AT2-R activation suppressing IL-1β has not previously been described.
MMP activity is known to be involved in the homeostatic balance of extracellular matrix remodelling in the kidney. AT2-R transfection had no effect on either MMP9 or MMP2 expression by mesangial cells, although both enzymes exhibited specific gender differences. These data do not reflect reports in the literature which demonstrate that MMP2 activity is reduced in AT2-R transfected vascular smooth muscle cells stimulated with AII. 32 The AT1-R is considered the major receptor for AII binding. Our study demonstrated that the AT2-R overexpression downregulated AT1-R expression in female cells. In contrast AT2-R transfection upregulated AT1-R expression in male mesangial cells. Our observations in female AT2-R transfected mesangial cells echo previously reported data in vascular smooth muscle cells, although in these studies gender was not disclosed. The sex specific expression of AT1-R may again be a function of oestrogen. Oestrogen regulates AT1-R expression by controlling the leader sequence of receptor mRNA binding proteins. 33 This may explain why in hypertensive rat models AT1-R expression is higher in the renal cortex of males than of females 34 and that lower ratios of AT1-R/AT2-R have been reported in female spontaneously hypertensive rats. 29 The lack of oestrogen may account for why male AT2-R transfected mesangial cells exhibited an upregulation of AT1-R expression.
The AT2-R is a G protein coupled receptor known to stimulate the bradykinin (bk)/nitric oxide (NO)/cGMP cascade. 10 In these respects the AT2-R has comparable properties to those of the bradykinin B2 receptor (BkB2-R), the major functional receptor of the kallikrein-kinin system. The two receptors may even operate in unison in counter regulating the detrimental effects of AT1-R binding. During AT1-R blockade AT2-R binding causes intracellular acidification through inhibition of the amiloride sensitive Na + /H + exchanger activity resulting in enhancement of kallikrein activity producing more bradykinin. 24 We and others have shown that enhancing kallikrein expression is beneficial to the kidney by slowing down the scarring process. [35] [36] [37] In the current study kallikrein mRNA levels were found to be suppressed by AT2-R over expression. This suppression of kallikrein transcription was unexpected, not least because we have previously shown that knock-down of kallikrein gene expression resulted in a pro-fibrotic mesangial cell phenotype. 18 Our data strongly suggest that regulation of AT2-R and kallikrein genes is linked.
AT2-R transfection had no effect upon either BkB2-R or BkB1-R expression in female cells. This observation was surprising as bradykinin B2 receptor expression is also known to be regulated by oestrogen. 38 However, the BkB1-R was upregulated in male AT2-R transfected cells treated with MCM. Both receptors mediate their actions via the production of NO, albeit via different enzymes (BkB2 R via eNOS and BkB1 R via iNOS). Nitric oxide has been shown to antagonise many of the effects of the vasoconstrictor and pro-fibrotic agent angiotensin II. 39 As eNOS expression was also upregulated in male AT2-R transfected cells treated with MCM it would suggest that anti-fibrotic pathways are activated in AT2-R transfected male mesangial cells treated with MCM and may impact on the observed trend towards lower baseline fibronectin levels.
An increase in BkB1 receptor in AT2-R over-expressing cells intuitively flies in the face of a protective response as a great deal of evidence has implicated this receptor with injury and inflammation. For example genetic deletion studies in a rat unilateral ureteral obstruction model or BkB1R blockade experiments in murine ischemia reperfusion injury have been shown to result in the attenuation of injury, inflammation and fibrosis. 40, 41 However, Kakoki et al., in their ischaemia reperfusion injury studies on BkB1R and BkB2R knockout mice, demonstrated that both receptors have protective functions. 42 Moreover, BkB1-R activation studies have also been shown to have anti-inflammatory effects in rat microglial cells downregulating LPS induced release of IL-1β. 43 The latter observations may also explain why we observed a down regulation of IL-1β release in MCM treated male AT2-R transfected cells concomitantly with an increase in BkB1-R expression.
Although AT2-R transfection exerted its most obvious anti-fibrotic effect in female mesangial cells stimulated with MCM by decreasing secreted fibronectin levels, most of the cytoprotective effects of AT2-R transfection impacted on male mesangial cells stimulated with MCM, particularly in the context of the genes involved with the kallikreinkinin system. This may suggest that males would benefit more from AT2-R manipulation than female cells whose innate phenotype in the context of hormonal control already bestows a better outcome.
All the effects of AT2-R over-expression in our study occurred in the absence of exogenous addition of AII. We have previously shown that treatment of rat mesangial cells with 10 6 M angiotensin II had no significant effect upon fibronectin secretion into culture supernatants compared to cells grown in normal medium 44 (which is in accord with the observations of others 45 ). Moreover, we have not detected AII in MCM (unpublished data). The observed reduction in fibronectin therefore, is unlikely to have occurred as a result of an attenuation of classic pro-fibrotic AII actions, further suggesting that the effects of AT2-R over-expression occurred in a ligand-independent fashion. Over-expression of AT2-R in fibroblasts in the absence of AII has previously been reported to enhance apoptosis. 46 Similar effects have been demonstrated in prostate cancer cells. 13 More significantly, with respect to this study, transient AT2-R-transfection of vascular smooth muscle cells has been reported to result in the upregulation of bradykinin and inducible NO synthase production in a ligand independent fashion, an effect which also concomitantly down regulated AT1a-R expression. 12 In a similar vein constitutively active homo-oligomeric AT2-R expression has been reported to induce cell signalling independent of receptor conformational change or ligand stimulation. 47 It would appear that generally, where AII is the protagonist exerting its effects via AT1-R activation, increased AT2-R signalling via AT1-R antagonism or AT2-R over-expression attenuates the AII-induced lesion. However, AT2-R overexpression in the absence of AII, can result in the transduction of signals resulting in a protection from injury, although the precise mechanisms of this phenomenon are yet to be fully determined.
One could argue that the results of over-expression studies do not reflect the physiological function of the receptor, not least because expression in adults is very low and is only normally activated in response to a stimulus, such as may be experienced during vascular injury. Nonetheless the observations provide a platform for further investigations into the mechanisms underlying ligand-independent receptor signalling with a view to developing novel receptor modulation strategies for treatment of reno-vascular disease.
The prevalence of cardiovascular disease and more rapid progression of renal disease in males compared to premenopausal females has been the subject of investigation of a vast number of studies. While oestrogen is generally considered to be protective the underlying mechanisms for sex specificity are still controversial. The fact that we observed some gender specific differences in response to AT2-R transfection is not entirely surprising as the AT2-R is located on the X chromosome. 48 Some differences were observed in the cells independent of AT2-R over-expression, again not entirely unexpected as components of the renin-angiotensin system are known to be regulated by sex hormones. 15 However, whilst it has been widely reported that sex hormones can directly affect cellular responses to injury, we have also previously shown that in the absence of the influence of hormones chromosomal gender per se may also affect the response of mesangial cells to injury. 14 It has to be said at this juncture that although the experiments in this study were carried out in the absence of endogenously added hormones one cannot eliminate any hormonal preconditioning that may have occurred in situ prior to preparation of the primary cell cultures. We have previously shown that male mesangial cells constitutively produce more fibronectin, profibrotic growth factors and matrix modulating enzymes than females cells. 14 However, what specific aspect of the male genotype results in the profibrotic phenotype is yet to be determined, although it is likely to involve multifactorial processes. In the current study the genes which are known to be regulated by oestrogen response elements were preferentially upregulated in male rather than female AT2-R transfected cells treated with MCM, suggesting that the oestrogen response elements did not play a regulatory role in their expression under our experimental conditions and further suggests that the observations were independent of hormonal control. It is worthy of note that others have shown that male kidneys do not seem to be influenced by lack of oestrogen receptors (ERα) suggesting the 'kidney knows its sex'. 49 The gender differences also highlight the pitfalls which may arise when interpreting data from single sex experiments.
Conclusion
This in vitro study has demonstrated that simple overexpression of AT2-R impacts on the expression of a number of interrelated genes that are generally considered cytoprotective to the kidney, implying that the receptor plays an important role in modulating fibrosis using mechanisms which are independent of blood pressure control and exogenous ligand stimulation.
